Your browser doesn't support javascript.
loading
Impact of naturally occurring variation in the human papillomavirus (HPV) 33 capsid proteins on recognition by vaccine-induced cross-neutralizing antibodies.
Godi, Anna; Bissett, Sara L; Miller, Elizabeth; Beddows, Simon.
Affiliation
  • Godi A; Virus Reference Department, Public Health England, London, UK.
  • Bissett SL; Virus Reference Department, Public Health England, London, UK.
  • Miller E; National Vaccine Evaluation Consortium, Public Health England, London, UK.
  • Beddows S; Virus Reference Department, Public Health England, London, UK.
J Gen Virol ; 98(7): 1755-1761, 2017 Jul.
Article in En | MEDLINE | ID: mdl-28691664
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomavirus Infections / Capsid Proteins / Alphapapillomavirus / Papillomavirus Vaccines / Antibodies, Neutralizing / Antibodies, Viral Limits: Humans Language: En Journal: J Gen Virol Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomavirus Infections / Capsid Proteins / Alphapapillomavirus / Papillomavirus Vaccines / Antibodies, Neutralizing / Antibodies, Viral Limits: Humans Language: En Journal: J Gen Virol Year: 2017 Document type: Article Affiliation country: Country of publication: